BIOMAT Database Logo BIOMAT Database Logo

[Agranulocytosis treatment with rhGM-CSF]. 1989

U Rosien, and G Benker, and G Brittinger, and D Reinwein

UI MeSH Term Description Entries
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D003115 Colony-Stimulating Factors Glycoproteins found in a subfraction of normal mammalian plasma and urine. They stimulate the proliferation of bone marrow cells in agar cultures and the formation of colonies of granulocytes and/or macrophages. The factors include INTERLEUKIN-3; (IL-3); GRANULOCYTE COLONY-STIMULATING FACTOR; (G-CSF); MACROPHAGE COLONY-STIMULATING FACTOR; (M-CSF); and GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; (GM-CSF). MGI-1,Macrophage-Granulocyte Inducer,Colony Stimulating Factor,Colony-Stimulating Factor,MGI-1 Protein,Myeloid Cell-Growth Inducer,Protein Inducer MGI,Cell-Growth Inducer, Myeloid,Colony Stimulating Factors,Inducer, Macrophage-Granulocyte,Inducer, Myeloid Cell-Growth,MGI 1 Protein,MGI, Protein Inducer,Macrophage Granulocyte Inducer,Myeloid Cell Growth Inducer
D005260 Female Females
D006133 Growth Substances Signal molecules that are involved in the control of cell growth and differentiation. Mitogens, Endogenous,Endogenous Mitogens
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000380 Agranulocytosis A decrease in the number of GRANULOCYTES; (BASOPHILS; EOSINOPHILS; and NEUTROPHILS). Granulocytopenia,Agranulocytoses,Granulocytopenias
D016178 Granulocyte-Macrophage Colony-Stimulating Factor An acidic glycoprotein of MW 23 kDa with internal disulfide bonds. The protein is produced in response to a number of inflammatory mediators by mesenchymal cells present in the hemopoietic environment and at peripheral sites of inflammation. GM-CSF is able to stimulate the production of neutrophilic granulocytes, macrophages, and mixed granulocyte-macrophage colonies from bone marrow cells and can stimulate the formation of eosinophil colonies from fetal liver progenitor cells. GM-CSF can also stimulate some functional activities in mature granulocytes and macrophages. CSF-GM,Colony-Stimulating Factor, Granulocyte-Macrophage,GM-CSF,Histamine-Producing Cell-Stimulating Factor,CSF-2,TC-GM-CSF,Tumor-Cell Human GM Colony-Stimulating Factor,Cell-Stimulating Factor, Histamine-Producing,Colony Stimulating Factor, Granulocyte Macrophage,Granulocyte Macrophage Colony Stimulating Factor,Histamine Producing Cell Stimulating Factor,Tumor Cell Human GM Colony Stimulating Factor

Related Publications

U Rosien, and G Benker, and G Brittinger, and D Reinwein
Successful treatment of myelodysplastic syndrome-associated anaemia with rhGM-CSF.
June 1994, Presse medicale (Paris, France : 1983),
U Rosien, and G Benker, and G Brittinger, and D Reinwein
Recovery of carbimazole-induced agranulocytosis following recombinant granulocyte-macrophage colony stimulating factor (rhGM-CSF) administration.
January 1993, Haematologica,
U Rosien, and G Benker, and G Brittinger, and D Reinwein
Treatment of non-healing ulcers with rhGM-CSF and skin grafts.
April 1994, Lancet (London, England),
U Rosien, and G Benker, and G Brittinger, and D Reinwein
Treatment of drug-induced agranulocytosis with recombinant GM-CSF.
November 1990, Journal of internal medicine,
U Rosien, and G Benker, and G Brittinger, and D Reinwein
Clomipramine-induced agranulocytosis and its treatment with G-CSF.
March 1993, The American journal of psychiatry,
U Rosien, and G Benker, and G Brittinger, and D Reinwein
rhGM-CSF vs placebo following rhGM-CSF-mobilized PBPC transplantation: a phase III double-blind randomized trial.
February 1997, Bone marrow transplantation,
U Rosien, and G Benker, and G Brittinger, and D Reinwein
Combination treatment of acute myeloblastic leukemia with rhGM-CSF and standard induction chemotherapy.
January 1993, Cancer investigation,
U Rosien, and G Benker, and G Brittinger, and D Reinwein
Treatment of drug-induced agranulocytosis with colony stimulating factors (G-CSF or GM-CSF).
January 1996, Archivum immunologiae et therapiae experimentalis,
U Rosien, and G Benker, and G Brittinger, and D Reinwein
Local peri-lesional therapy with rhGM-CSF for Kaposi's sarcoma.
May 1993, Lancet (London, England),
U Rosien, and G Benker, and G Brittinger, and D Reinwein
Renaturation and purification of rhGM-CSF with ion-exchange chromatography.
January 2007, Biotechnology progress,
Copied contents to your clipboard!